CorMedix, Inc.
(NASDAQ : CRMD)

( )
CRMD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.63%475.871.0%$748.06m
ABTAbbott Laboratories 0.07%120.990.8%$598.63m
DHRDanaher Corp. 1.09%234.880.7%$595.54m
MDTMedtronic Plc -0.10%121.880.6%$592.69m
ALGNAlign Technology, Inc. 1.44%601.116.3%$379.40m
ISRGIntuitive Surgical, Inc. -0.67%779.262.3%$346.47m
SYKStryker Corp. -0.62%251.741.3%$306.81m
DXCMDexCom, Inc. 1.11%387.157.8%$285.55m
BDXBecton, Dickinson & Co. -0.21%247.411.0%$273.61m
BSXBoston Scientific Corp. 0.03%39.331.0%$248.40m
EWEdwards Lifesciences Corp. -0.19%85.830.4%$229.79m
BAXBaxter International, Inc. -0.47%84.521.8%$224.76m
IDXXIDEXX Laboratories, Inc. 0.71%506.433.7%$222.54m
AAgilent Technologies, Inc. -0.51%131.241.6%$184.07m
NVSTEnvista Holdings Corp. -1.06%41.830.0%$166.90m

Company Profile

CorMedix, Inc. operates as a pharmaceutical and medical device company. The firm seeks to license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ.